ID

23842

Description

Study part: Exploratory Biomarker Research Week 38 / Early Withdrawal visit.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Mots-clés

Versions (1)
  1. 15/07/2017 15/07/2017 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

15 juillet 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Exploratory Biomarker Research Week 38 Mepolizumab HES NCT00086658

Anglais

Exploratory Biomarker Research Week 38

1 Formulaires  
EXPLORATORY BIOMARKER RESEARCH
Description

EXPLORATORY BIOMARKER RESEARCH

Alias
UMLS CUI-1
C0005516
Has the subject provided written consent for exploratory biomarker research?
Description

informed consent biomarker

Type de données

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0005516
Date of Assessment
Description

Date of Assessment

Type de données

date

Alias
UMLS CUI [1]
C2985720
Date of Assessment Skin Biopsy
Description

Date of Assessment Skin Biopsy

Type de données

date

Alias
UMLS CUI [1,1]
C2985720
UMLS CUI [1,2]
C0150866
Date of Assessment GI Biopsy
Description

Date of Assessment GI Biopsy

Type de données

date

Alias
UMLS CUI [1,1]
C2985720
UMLS CUI [1,2]
C0005558
UMLS CUI [1,3]
C0017189
Retour au début de la page

Similar models

Exploratory Biomarker Research Week 38

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
EXPLORATORY BIOMARKER RESEARCH
C0005516 (UMLS CUI-1)
informed consent biomarker
Item
Has the subject provided written consent for exploratory biomarker research?
boolean
C0021430 (UMLS CUI [1,1])
C0005516 (UMLS CUI [1,2])
Date of Assessment
Item
Date of Assessment
date
C2985720 (UMLS CUI [1])
Date of Assessment Skin Biopsy
Item
Date of Assessment Skin Biopsy
date
C2985720 (UMLS CUI [1,1])
C0150866 (UMLS CUI [1,2])
Date of Assessment GI Biopsy
Item
Date of Assessment GI Biopsy
date
C2985720 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
C0017189 (UMLS CUI [1,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial